CAITLIN LUTZ: Open Payments
NPI 1457724585 · WESTMINSTER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,683 in 82 payments from 13 companies in 2025. Trend: 2023 $993 · 2024 $1,967 · 2025 $1,683
Food & beverage: $1,485Education: $198
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 24 | $325 |
| Regeneron Healthcare Solutions, Inc. | 6 | $245 |
| Janssen Biotech, Inc. | 7 | $213 |
| Novartis Pharmaceuticals Corporation | 11 | $179 |
| ABBVIE INC. | 12 | $174 |
| E.R. Squibb & Sons, L.L.C. | 4 | $149 |
| GENZYME CORPORATION | 4 | $101 |
| PFIZER INC. | 3 | $63 |
| Incyte Corporation | 3 | $62 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $61 |
Products named: VTAMA, DUPIXENT, TREMFYA, Sotyktu, COSENTYX, RINVOQ, SKYRIZI, CIBINQO.
Industry payments across MD — which companies pay providers there.
